Ok, Histonetters I have another question for you.

According the CAP checklist question:

 

ANP.22750  Phase II

 

Has the laboratory documented evaluation of new antibody lots and new
antibodies, prior to use in patient diagnosis?

 

NOTE:  For newly introduced antibodies, staining conditions should be
evaluated in cases expected to be positive and negative for the antigen
of interest. Ideally, a series of sufficient size should be run to give
the laboratory an idea of the sensitivity and specificity of the test.  

 

How are you folks handling this question when using Ventana?

 

Thanks a bunch.  

 

Sharon Davis-Devine, CT (ASCP)

Cytology Supervisor

Carle Clinic

602 West University

Urbana, Illinois 61801

Phone:  217-383-3572

Email:  sharon.davis-devine@carle.com

 

_______________________________________________
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet